Antipsychotic treatment response in schizophrenia-Reference-Cited by-同舟云学术

Antipsychotic treatment response in schizophrenia

Published:2012-11-01 Issue:21 Volume:69 Page:1872-1879
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Gardner Kristen N.¹,Bostwick Jolene R.²

Affiliation:

1. College of Pharmacy, University of Michigan, Ann Arbor

2. Department of Clinical, Social, and Administrative Sciences, College of Pharmacy, University of Michigan, and Clinical Pharmacist, Adult Psychiatry, University of Michigan Health System, Ann Arbor

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/69/21/1872/28361937/ajhp1872.pdf

Reference48 articles.

1. Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders;Agid;Schizophr Res.,2008

2. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected;Agid;Arch Gen Psychiatry,2003

3. The “delayed onset” of antipsychotic action—an idea whose time has come and gone;Agid;J Psychiatry Neurosci.,2006

4. Evidence for onset of antipsychotic effects within the first 24 hours of treatment;Kapur;Am J Psychiatry,2005

5. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder;Kane;J Clin Psychiatry,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between efficacy and common metabolic parameters in first-treatment drug-naïve patients with early non-response schizophrenia: a retrospective study;Annals of General Psychiatry;2023-02-17

2. Relationship between efficacy and common metabolic parameters in first- treatment drug-naïve patients with early non-response schizophrenia: a retrospective study;2022-12-05

3. Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2022-03

4. The use of antipsychotics in targeted therapy of schizophrenia — prospects and challenges (for example, amisulpride).;Ukrains'kyi Visnyk Psykhonevrolohii;2021-07-15

5. White Matter in Schizophrenia Treatment Resistance;American Journal of Psychiatry;2019-10-01